Both attractive drugs below could be approved by health canada within next month which could push this low float stock significantly higher ... Cipher Pharmaceuticals Announces A-101 40% Topical Solution Accepted for Review by Health Canada....Dec. 18, 2018 https://cipher.investorroom.com/2018-12-18-Cipher-Pharmaceuticals-Announces-A-101-40-Topical-Solution-Accepted-for-Review-by-Health-Canada Cipher Pharmaceuticals Announces PLECANATIDE Accepted for Review by Health Canada....Dec. 17, 2018 https://cipher.investorroom.com/2018-12-17-Cipher-Pharmaceuticals-Announces-PLECANATIDE-Accepted-for-Review-by-Health-Canada